https://www.cnn.com/2024/03/19/tech/novo-nordisk-ai-supercomputer/index.html
LondonCNN —
The owner of Novo Nordisk, the drugmaker that gave the world Ozempic and Wegovy, is funding a new supercomputer powered by Nvidia’s artificial intelligence technology with a key aim of discovering new medicines and treatments.
The Novo Nordisk Foundation has awarded France’s Eviden a contract to build what the computing company says will be one of the world’s most powerful supercomputers, able to process vast amounts of data using AI.
[URL='https://www.cnn.com/2024/03/19/tech/novo-nordisk-ai-supercomputer/index.html']It should provide “unprecedented potential to accelerate groundbreaking scientific discoveries in areas such as drug discovery, disease diagnosis and treatment,” Cédric Bourrasset, Eviden’s head of quantum computing, said in a statement.[/URL]
LondonCNN —
The owner of Novo Nordisk, the drugmaker that gave the world Ozempic and Wegovy, is funding a new supercomputer powered by Nvidia’s artificial intelligence technology with a key aim of discovering new medicines and treatments.
The Novo Nordisk Foundation has awarded France’s Eviden a contract to build what the computing company says will be one of the world’s most powerful supercomputers, able to process vast amounts of data using AI.
[URL='https://www.cnn.com/2024/03/19/tech/novo-nordisk-ai-supercomputer/index.html']It should provide “unprecedented potential to accelerate groundbreaking scientific discoveries in areas such as drug discovery, disease diagnosis and treatment,” Cédric Bourrasset, Eviden’s head of quantum computing, said in a statement.[/URL]